At Biocept, we are dedicated to improving outcomes for cancer patients.
We focus on developing innovative diagnostic solutions that give patients and doctors the information they need.
Our experts have spent years working to change the way physicians look at cerebrospinal fluid (CSF) in cancer patients.
We have developed a unique, patented methodology to isolate cancer material that is shed from the primary tumor, such as CSF tumor cells (CSF-TCs) and cell-free DNA (cfDNA).
Using our proprietary CNSide™ assay to analyze and interrogate CSF-TCs and cfDNA for certain biomarkers, physicians can be better informed about the actionable molecular information associated with a patient’s metastatic cancer and develop a personalized cancer treatment plan.
Biocept’s services are available to all disciplines of oncology clinicians and researchers. Our technology has been used by doctors in thousands of patient cases. We partner with industry leaders and major cancer centers, continually advancing the field of cancer diagnostics.
Business Development, Clinical Trial, and Biopharmaceutical Services
Biocept is dedicated to supporting its partners, collaborators, and clients with our unique CNSide™ CSF-TC and cfDNA technology platforms for rare event detection and genetic characterization. Our CLIA-licensed and CAP-accredited laboratory combines a highly trained professional staff who are experienced in assay development with innovative instrumentation for optimal test results and quality control.
Our CNSide™ platform provides flexibility for developing assays with unique requirements for our pharma or biotechnology partners. This development can be performed in our CLIA laboratory. We focus on providing high-level, personalized service to our clients, addressing critical questions of interest to them including:
- Assay development
- Patient population profiling
- Determination of patient eligibility/stratification for clinical trials
- Measuring efficacy endpoints
- Correlative science studies
Licenses and Certifications
Biocept is fully approved, licensed and accredited by the states of California, Maryland, Pennsylvania, and Rhode Island; CLIA, and Medicare/Medicaid and CAP.
We strictly adhere to all HIPAA Policies and Procedures designed to prevent violations by our Company and our employees.
View License Documentation
Partner with Biocept
Contact us to learn how Biocept can support your research and testing.
Contact Customer Service for assistance at 888.332.7729 or email us at firstname.lastname@example.org.